Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$209.01 - $232.56 $7.5 Million - $8.34 Million
35,870 Added 3.15%
1,176,170 $257 Million
Q4 2023

Feb 13, 2024

BUY
$197.69 - $227.29 $55.3 Million - $63.6 Million
279,628 Added 32.49%
1,140,300 $259 Million
Q3 2023

Nov 08, 2023

BUY
$201.05 - $221.7 $301,776 - $332,771
1,501 Added 0.17%
860,672 $173 Million
Q2 2023

Aug 09, 2023

BUY
$211.93 - $241.33 $608,662 - $693,099
2,872 Added 0.34%
859,171 $207 Million
Q1 2023

Apr 27, 2023

BUY
$213.32 - $257.83 $1.76 Million - $2.13 Million
8,273 Added 0.98%
856,299 $196 Million
Q4 2022

Feb 13, 2023

BUY
$203.72 - $248.97 $3.2 Million - $3.92 Million
15,731 Added 1.89%
848,026 $200 Million
Q3 2022

Nov 14, 2022

SELL
$204.81 - $262.19 $23.3 Million - $29.8 Million
-113,649 Reduced 12.01%
832,295 $171 Million
Q2 2022

Aug 10, 2022

BUY
$213.86 - $277.87 $29.8 Million - $38.7 Million
139,269 Added 17.26%
945,944 $222 Million
Q1 2022

May 16, 2022

BUY
$259.82 - $298.18 $33.9 Million - $38.9 Million
130,583 Added 19.31%
806,675 $213 Million
Q4 2021

Feb 11, 2022

SELL
$271.6 - $314.21 $5.33 Million - $6.17 Million
-19,623 Reduced 2.82%
676,092 $212 Million
Q3 2021

Nov 12, 2021

SELL
$274.82 - $308.34 $776,641 - $871,368
-2,826 Reduced 0.4%
695,715 $196 Million
Q2 2021

Aug 05, 2021

BUY
$251.87 - $278.14 $2.89 Million - $3.19 Million
11,485 Added 1.67%
698,541 $193 Million
Q1 2021

May 14, 2021

SELL
$204.88 - $255.03 $12.2 Million - $15.2 Million
-59,707 Reduced 8.0%
687,056 $175 Million
Q4 2020

Feb 11, 2021

BUY
$186.91 - $214.42 $140 Million - $160 Million
746,763 New
746,763 $152 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Veritas Investment Partners (Uk) Ltd. Portfolio

Follow Veritas Investment Partners (Uk) Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritas Investment Partners (Uk) Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Veritas Investment Partners (Uk) Ltd. with notifications on news.